Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gachon University Gil Medical Center
Inclusion criteria
1. pathologically confirmed BL or BL-U by World Health Organization 2008 criteria
2. age \>20 yrs
3. received rituximab+chemotherapy as first-line treatment
4. with measurable or evaluable lesion
5. with complete set of clinical and laboratory data for the analysis
Age
20–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. pathologically confirmed Burkitt's lymphoma (BL) or High grade B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and BL (BL-U) by WHO 2008 criteria
2. age \>20 yrs
3. received rituximab+chemotherapy as first-line treatment
4. with measurable or evaluable lesion
You may not be if
1\. patients with BL or BL-U previously treated with rituximab
